pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 28·2 min read
save

STAT+: Google’s clinical director on AI challenges

In this edition of STAT Health Tech newsletter: a conversation with Google's clinical director, an update on Doctronic's Utah experiment, and more.

Apr 28, 2026·read at STAT ↗

STAT PlusNewsletterHealth Tech Newsletter Google’s clinical director on AI challenges You’re reading the web edition of STAT Health Tech newsletter Manage alerts for this article Email this article Share this article By Mario AguilarApril 28, 2026 Health Tech Correspondent Mario Aguilar[email protected]Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter.

You can reach Mario on Signal at mariojoze.13. You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Good morning health tech readers!Advertisement Does letting general purpose chatbots talk to people with a mental health crisis do more good than harm? Google answers below. STAT+ Exclusive Story Already have an account?

Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%!

Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In health tech, Health Tech Newsletter, Pharmaceuticals, STAT+ Submit a correction requestReprints Mario Aguilar Health Tech Correspondent Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

Newsletter Understand how science, health policy, and medicine shape the world every day Recommended Health Tech Newsletter April 23, 2026 STAT Plus: AMA calls for regulatory crackdown on chatbots, wellness AI Health Tech Newsletter April 21, 2026 STAT Plus: Kennedy hints at coming breakthrough device announcement Advertisement Health Tech Newsletter April 16, 2026 STAT Plus: Medicare may nix breakthrough device payment pathway Health Tech Newsletter April 14, 2026 STAT Plus: Hospitals offer chatbots to fight off ChatGPT Health Tech Newsletter April 9, 2026 STAT Plus: FDA rejects an industry proposal to deregulate some AI devices Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
453 words · retrieved Apr 28
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Psychiatry & CNS

related stories

  • Apr 27STAT+: Astellas retries XLMTM gene therapy after deathsSTAT
  • Apr 27What’s the true risk for eating disorders with GLP-1s?STAT
  • Apr 27STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trialSTAT
  • Apr 27STAT+: Oruka’s long-acting psoriasis therapy posts strong results in mid-stage studySTAT
  • Apr 27STAT+: Veradermics’ hair loss drug succeeds in late-stage trialSTAT